BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17275810)

  • 61. Bone morphogenetic protein-2 suppresses invasiveness of TSU-Pr1 cells with the inhibition of MMP-9 secretion.
    Kumagai T; Shimizu T; Takeda K
    Anticancer Res; 2006; 26(1A):293-8. PubMed ID: 16475709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells.
    Clement JH; Raida M; Sänger J; Bicknell R; Liu J; Naumann A; Geyer A; Waldau A; Hortschansky P; Schmidt A; Höffken K; Wölft S; Harris AL
    Int J Oncol; 2005 Aug; 27(2):401-7. PubMed ID: 16010421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases.
    Schoppmeyer K; Frühauf N; Oldhafer K; Seeber S; Kasimir-Bauer S
    Oncol Rep; 2006 Feb; 15(2):449-54. PubMed ID: 16391868
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells.
    Deng H; Ravikumar TS; Yang WL
    Cancer Lett; 2007 Oct; 256(2):207-17. PubMed ID: 17640799
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
    Kim IY; Lee DH; Lee DK; Kim WJ; Kim MM; Morton RA; Lerner SP; Kim SJ
    Cancer Res; 2004 Oct; 64(20):7355-60. PubMed ID: 15492256
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death.
    Raida M; Clement JH; Ameri K; Han C; Leek RD; Harris AL
    Int J Oncol; 2005 Jun; 26(6):1465-70. PubMed ID: 15870857
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Programmable cells of monocytic origin (PCMO): a source of peripheral blood stem cells that generate collagen type II-producing chondrocytes.
    Pufe T; Petersen W; Fändrich F; Varoga D; Wruck CJ; Mentlein R; Helfenstein A; Hoseas D; Dressel S; Tillmann B; Ruhnke M
    J Orthop Res; 2008 Mar; 26(3):304-13. PubMed ID: 17963214
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bone morphogenetic protein expression in newborn rat kidneys after prenatal exposure to radiofrequency radiation.
    Pyrpasopoulou A; Kotoula V; Cheva A; Hytiroglou P; Nikolakaki E; Magras IN; Xenos TD; Tsiboukis TD; Karkavelas G
    Bioelectromagnetics; 2004 Apr; 25(3):216-27. PubMed ID: 15042631
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma.
    Gui X; Guzman G; Dobner PR; Kadkol SS
    Peptides; 2008 Sep; 29(9):1609-15. PubMed ID: 18541341
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation.
    Beppu H; Mwizerwa ON; Beppu Y; Dattwyler MP; Lauwers GY; Bloch KD; Goldstein AM
    Oncogene; 2008 Feb; 27(8):1063-70. PubMed ID: 17700526
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone morphogenetic proteins are expressed by both bone-forming and non-bone-forming lesions.
    Khurana JS; Ogino S; Shen T; Parekh H; Scherbel U; DeLong W; Feldman MD; Zhang PJ; Wolfe HJ; Alman BA
    Arch Pathol Lab Med; 2004 Nov; 128(11):1267-69. PubMed ID: 15508192
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulatory expression of bone morphogenetic protein-6 system in aldosterone production by human adrenocortical cells.
    Inagaki K; Otsuka F; Suzuki J; Otani H; Takeda M; Kano Y; Miyoshi T; Yamashita M; Ogura T; Makino H
    Regul Pept; 2007 Feb; 138(2-3):133-40. PubMed ID: 17067690
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
    Yang S; Pham LK; Liao CP; Frenkel B; Reddi AH; Roy-Burman P
    Cancer Res; 2008 Jan; 68(1):198-205. PubMed ID: 18172312
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Expression of minichromosome maintenance protein 2 in colonic adenocarcinoma, adenoma and normal colonic mucosa and its clinical significance].
    Wang Y; Zhou ZG; Xia QJ; Zhang WY; Li HG; Wang R
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):465-8. PubMed ID: 18803052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis.
    Voisin T; El Firar A; Fasseu M; Rouyer-Fessard C; Descatoire V; Walker F; Paradis V; Bedossa P; Henin D; Lehy T; Laburthe M
    Cancer Res; 2011 May; 71(9):3341-51. PubMed ID: 21415167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis.
    Bramlage CP; Müller GA; Tampe B; Bevanda J; Maatouk I; Koziolek M; Lange K; Ahrens K; Schmid H; Cohen CD; Bramlage P; Kretzler M; Strutz F
    J Nephrol; 2011; 24(5):647-55. PubMed ID: 21319131
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
    Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
    Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.